Pharmaceutical companies

Drug makers still raising prices, but seeking fewer hikes

Data: 46brooklyn Research; Chart: Naema Ahmed/Axios

The number of price increases on brand-name drugs fell by about half from 2015 through 2018, according to data provided to Axios and compiled by 46brooklyn Research, a nonprofit firm that tracks drug prices.

Yes, but: Several companies still raised list prices frequently and at rates well above inflation, and many medications that saw higher prices had already lost patent protection or are nearing a patent expiration.

Eli Lilly's buyout of Loxo Oncology took only 2 weeks

Eli Lilly's logo on a phone screen.
Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images

Pharmaceutical company Eli Lilly made its first offer to buy Loxo Oncology on Dec. 20, 2018, and it was eager to close the deal before the J.P. Morgan Healthcare Conference last week, according to new regulatory documents filed by Loxo.

Between the lines: Acquisitions usually take several months of negotiations, not 2 weeks, but both sides in this $8 billion deal moved extraordinarily quickly in part to make a big splash at the health care industry's signature event.

More stories loading.